EligibleTrials

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

Recruiting · NCT06425848 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Kansas Medical Center

View the official record on ClinicalTrials.gov →
Heart Failure

Interventions studied

Observational

What this trial is about

The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmonary artery pressure sensor at participating centers to advance scientific knowledge about ambulatory hemodynamics monitoring and HF (Heart Failure) therapies. The data collected will be used for retrospective studies, quality improvement, identifying research cohorts, and member-initiated research.

Who can take part

Age range
18 Years to 100 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

12 locations listed across 10 US states.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.